Ocular Therapeutix (OCUL) – FDA News
-
Ocular Therapeutix (OCUL) Reports Positive Topline Phase 1 Data for AXPAXLI
-
Ocular Therapeutix (OCUL) Announces FDA Agreement to Amend Special Protocol Assessment for Trial of AXPAXLI
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to OCUL Stock Lookup